{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:33:18Z","timestamp":1793489598147,"version":"4.5.0"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,4,16]],"date-time":"2004-04-16T00:00:00Z","timestamp":1082073600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:p>The plasma and urine pharmacokinetics of flunixin\u2010meglumine (FNX) in cats were examined using a total of 12 adult animals. After an intravenous injection of FNX (2\u2003mg\/kg), the plasma concentration time curves showed a profile of a two\u2010compartment open model with an elimination half\u2010life of 6.6\u2003h. In spite of high plasma protein binding (&gt;99%), the<jats:italic>V<\/jats:italic><jats:sub>d<\/jats:sub><jats:italic>\u03b2<\/jats:italic>was unusually large, 0.7\u2003L\/kg. Although the recovery of FNX from urine was only 0.4% of the dose, the estimated inherent renal clearance closely corresponded to the renal plasma flow rate, indicating that a renal active tubular secretion was involved in the pharmacokinetics of FNX. Cholestyramine (ChSA), an anion exchanger, was orally administered immediately before the FNX injection in order to determine the involvement of enterohepatic circulation in FNX pharmacokinetics. The elimination phase of the profile of FNX was prevented by the concomitant administration of ChSA, so it was concluded that the drug undergoes enterohepatic circulation in cats. Pravastatin (PV) is a specific substrate of the type\u20102 organic anion transporting polypeptide transporter (OATP\u20102) in human liver cells. The effect of a concomitant intravenous injection of PV with FNX was examined in order to determine the involvement of OATP\u20102 like transporter in the pharmacokinetics. The V1 and total body clearance were decreased after the injection of PV. In conclusion, at least two active transport mechanisms are involved in the pharmacokinetics of FNX in cats. One pathway is renal tubular secretion and the other is sinusoidal active uptake by liver cells. The latter may be responsible for the enterohepatic circulation of FNX in cats.<\/jats:p>","DOI":"10.1111\/j.1365-2885.2004.00551.x","type":"journal-article","created":{"date-parts":[[2004,4,16]],"date-time":"2004-04-16T11:53:02Z","timestamp":1082116382000},"page":"65-69","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver"],"prefix":"10.1111","volume":"27","author":[{"given":"Y.","family":"Horii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ikenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kokue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,16]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00278579"},{"key":"e_1_2_16_3_1","first-page":"891","article-title":"Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver","volume":"276","author":"Bossuyt X.","year":"1996","journal-title":"Journal of Pharmacology Experimental Therapeutics"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015847912059"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018924219540"},{"key":"e_1_2_16_6_1","first-page":"479","article-title":"A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats","volume":"22","author":"Fukuyama T.","year":"1994","journal-title":"The American Society for Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)31783-1"},{"key":"e_1_2_16_8_1","first-page":"235","article-title":"Pharmacokinetics of flunixin meglumine in dogs","volume":"46","author":"Hardie E.M.","year":"1985","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.52.37161"},{"key":"e_1_2_16_10_1","first-page":"63","article-title":"Effect of multiple dosing of ketoconazole on pharmacokinetics of midazolam, a cytochrome P\u2010450 3A substrate in beagle dogs","volume":"30","author":"Kuroha M.","year":"2001","journal-title":"The American Society for Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01062103"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0007-1935(91)90002-5"},{"issue":"1","key":"e_1_2_16_13_1","first-page":"73S","article-title":"Pharmacokinetics and dosage regimens of anti\u2010inflammatory drugs","volume":"21","author":"Lees P.","year":"1990","journal-title":"Annales de Recherches Veterinaires"},{"key":"e_1_2_16_14_1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2460\/ajvr.1992.53.3.372","article-title":"Effect of probenecid on the pharmacokinetics of flunixin meglumine and phenylbutazone in healthy mares","volume":"53","author":"Manuel J.","year":"1992","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.63.885"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.1989.9694230"},{"key":"e_1_2_16_17_1","first-page":"1650","article-title":"Disposition and enterohepatic circulation of diclofenac in dogs","volume":"30","author":"Tsuchiya T.","year":"1980","journal-title":"Drug Research"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199019010-00004"},{"key":"e_1_2_16_19_1","first-page":"31","volume-title":"General Pharmacology. Clinical Pharmacology","author":"Webster C.R.L.","year":"2001"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.4.879"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2004.00551.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.2004.00551.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T21:33:02Z","timestamp":1734298382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2004.00551.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1365-2885.2004.00551.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2004.00551.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}